Related Facts

• Atrial fibrillation ablation prevents recurrence of AFib

  Atrial fibrillation ablation, which involves using a catheter inserted into the heart to destroy electrical conduction tissue in or near the atria, prevents the recurrence of atrial fibrillation in up…  [ Get More Details ]

• t-PA cost savings

  The total annual benefit to society from t-PA use in the United States is around $363 million—$60 million in direct cost savings to society plus an additional 7,510 QALYs. This means…  [ Get More Details ]

• Identifying individuals at high risk for developing AFib

  Using simple bedside measures, identification of individuals at risk for developing atrial fibrillation is feasible. Selecting high-risk individuals for inclusion in atrial fibrillation prevention trials may also enhance prevention strategies.  [ Get More Details ]

• Cost of warfarin therapy for AFib patients

  In patients with nonvalvular atrial fibrillation (AF) and one additional stroke risk factor, warfarin therapy cost $8,000 per quality-adjusted life-year (QALY) saved.  [ Get More Details ]

• Per-patient annual cost of treating stroke in atrial fibrillation patients

  The per-patient annual cost of treating stroke in atrial fibrillation patients was found to be $1,485 in a wellcontrolled anti-coagulation clinic, $3,710 for those receiving warfarin in routine medical care,…  [ Get More Details ]